Michael D Green

20PUBLICATIONS
81CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 04, 2026
Polygenic risk scores for prediction of immune checkpoint inhibitor thyroid toxicity in diverse populations.

|Dec 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitors.

Daria Brinzevich, Virginia Falvello, Sadiq S Rehmani

|Sep 04, 2025
Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression.

Ashley N Pearson, Jessica Waninger, Amanda K Huber

|Dec 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer.

Victoria M Valvo, Qiang Zhang, Long Jiang

|Nov 07, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System.

Sean R Miller, Matthew Schipper, Lars G Fritsche

|Jun 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.

Jae Eun Choi, Yuanyuan Qiao, Ilona Kryczek

Pageof 4

Frequent Collaborators

6 joint publications

Alex K Bryant

5 joint publications

Theodore S Lawrence

3 joint publications

Ilona Kryczek

3 joint publications

Ashley N Pearson